Monographie - Eravacycline - Stabilis 4.0

Ultimo aggiornamento :
18/07/2024

Antibiotico

Eravacycline

Iniezione

Stabilità in soluzione

Stabilità in miscela

Fattori che influenzano la stabilità

Compatibilità

metodo di iniezione

Bibliografia

pdf

Struttura chimica

Nome commerciale

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Xerava

Stati Uniti d’America

Bibliografia

Iniezione

Bibliografia : Eravacycline

	tipo	pubblicazione
3531	Laboratorio	Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics Wockhardt 2014
4434	Rivista	Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration. Clin Ther 2019 ; 41, 10: 2162-2170.
4709	Laboratorio	XERAVA® (eravacycline) for injection, for intravenous use. HIGHLIGHTS OF PRESCRIBING INFORMATION. Tetraphase Pharmaceuticals. 2021
4801	Rivista	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales